GSI Capital Advisors’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-298,315
| Closed | -$5.17M | – | 37 |
|
|
2024
Q4 | $5.17M | Sell |
298,315
-405
| -0.1% | -$7.02K | 2.73% | 20 |
|
|
2024
Q3 | $5.56M | Buy |
+298,720
| New | +$5.56M | 2.78% | 18 |
|
|
2023
Q4 | – | Sell |
-299,392
| Closed | -$4.17M | – | 30 |
|
|
2023
Q3 | $4.17M | Sell |
299,392
-73,402
| -20% | -$1.02M | 2.92% | 17 |
|
|
2023
Q2 | $4.39M | Buy |
+372,794
| New | +$4.39M | 2.68% | 17 |
|
|
2023
Q1 | – | Sell |
-204,279
| Closed | -$2.54M | – | 29 |
|
|
2022
Q4 | $2.54M | Buy |
+204,279
| New | +$2.54M | 1.54% | 24 |
|
|
2021
Q4 | – | Sell |
-455,380
| Closed | -$6.7M | – | 39 |
|
|
2021
Q3 | $6.7M | Sell |
455,380
-31,524
| -6% | -$464K | 3.34% | 10 |
|
|
2021
Q2 | $8.86M | Buy |
486,904
+82,601
| +20% | +$1.5M | 4.09% | 9 |
|
|
2021
Q1 | $7.02M | Buy |
404,303
+73,003
| +22% | +$1.27M | 3.09% | 10 |
|
|
2020
Q4 | $5.76M | Buy |
331,300
+20,300
| +7% | +$353K | 3.5% | 11 |
|
|
2020
Q3 | $4.29M | Buy |
311,000
+20,800
| +7% | +$287K | 3.08% | 12 |
|
|
2020
Q2 | $4.19M | Buy |
290,200
+135,900
| +88% | +$1.96M | 3.39% | 15 |
|
|
2020
Q1 | $1.69M | Sell |
154,300
-88,000
| -36% | -$961K | 1.51% | 23 |
|
|
2019
Q4 | $5.17M | Buy |
242,300
+11,500
| +5% | +$245K | 3.09% | 12 |
|
|
2019
Q3 | $5.3M | Hold |
230,800
| – | – | 3.11% | 14 |
|
|
2019
Q2 | $4.54M | Sell |
230,800
-36,500
| -14% | -$719K | 2.9% | 14 |
|
|
2019
Q1 | $5.2M | Sell |
267,300
-25,200
| -9% | -$491K | 2.88% | 13 |
|
|
2018
Q4 | $4.82M | Buy |
+292,500
| New | +$4.82M | 2.72% | 15 |
|
|
2018
Q3 | – | Sell |
-224,000
| Closed | -$4.87M | – | 33 |
|
|
2018
Q2 | $4.87M | Buy |
224,000
+10,600
| +5% | +$230K | 2.54% | 15 |
|
|
2018
Q1 | $3.77M | Buy |
213,400
+57,900
| +37% | +$1.02M | 2.13% | 18 |
|
|
2017
Q4 | $2.92M | Buy |
155,500
+10,200
| +7% | +$191K | 1.61% | 22 |
|
|
2017
Q3 | $3.19M | Buy |
+145,300
| New | +$3.19M | 1.93% | 20 |
|